Showing results (731-740 of 3,591) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|April 24, 2014
Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patientsH E Raouf, A S Yassin, S A Megahed, et al.Journal of Viral Hepatitis|October 4, 2016
Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE studyB Fevery, T Verbinnen, M Peeters, et al.Journal of Viral Hepatitis|April 5, 2017
The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphomaC-E Huang, Y-H Yang, Y-Y Chen, et al.Journal of Viral Hepatitis|January 29, 2017
Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapyC-H Hung, J-H Wang, S-N Lu, et al.Journal of Viral Hepatitis|November 1, 2018
Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normalZhao Wu, Xiaoqin Dong, Guiqiang Wang, et al.Journal of Viral Hepatitis|November 1, 2018
Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patientsXiao-Qin Dong, Zhao Wu, Hong Zhao, et al.Journal of Viral Hepatitis|April 22, 2017
Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infectionA B Laaribi, D Bortolotti, N Hannachi, et al.Journal of Viral Hepatitis|April 19, 2017
HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjectsE Papasavvas, L Azzoni, X Yin, et al.Journal of Viral Hepatitis|March 22, 2019
Causes of death among persons diagnosed with hepatitis C infection in the pre- and post-DAA era in England: A record linkage studyRuth Simmons, Georgina Ireland, Samreen Ijaz, et al.Journal of Viral Hepatitis|March 22, 2019
Relationship between hepatitis B core-related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analoguesMilan J Sonneveld, Gertine W van Oord, Margo J van Campenhout, et al.Pageof 360